Stock Information

Lineage Cell Therapeutics Inc (LCTX)

Lineage Cell Therapeutics Inc logo
Ticker Symbol: LCTX
Exchange: NYSE
Sector: Biotechnology
Market Cap: $301.40 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -0.14
Revenue (TTM): $0.05 M
Dividend Yield: N/A
ROE: -71.14%

Latest News

Key Financials

Financial data not available